Search

Galectin Therapeutics Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

3.96 2.59

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

3.5300000000000002

Max

3.94

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-4.1M

-9.1M

Pelnas, tenkantis vienai akcijai

-0.14

Darbuotojai

9

EBITDA

2.2M

-827K

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+198.91% upside

Dividendai

By Acuity

Kitas uždarbis

2026-11-13

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

39M

354M

Ankstesnė atidarymo kaina

1.37

Ankstesnė uždarymo kaina

3.96

Naujienos nuotaikos

By Acuity

50%

50%

150 / 340 reitingas Healthcare

Galectin Therapeutics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-24 23:01; UTC

Shares of Galectin Therapeutics Inc. are lower in after-market trading, with notable volatility and a decline since Monday's close.

2026-08-21 19:16; UTC

Galectin Therapeutics Inc shares are higher today, maintaining a position above the 20-day moving average and near the upper end of their one-month range.

2026-08-20 20:06; UTC

Galectin Therapeutics Inc. shares are lower today, continuing a decline since Wednesday. The price remains above its 20-day moving average.

2026-08-18 19:56; UTC

Galectin Therapeutics Inc. shares are higher today, advancing since Monday's close despite earlier pulling back from session lows. The stock remains above its 20-day moving average.

2026-08-17 19:56; UTC

Galectin Therapeutics Inc. shares are trading higher, recovering from an earlier low and positioned above the 20-day moving average. No specific news was identified.

2026-08-14 19:21; UTC

News

Galectin Therapeutics reports a net loss of $9.2 million for Q2, missing estimates, contributing to a decline in shares during the session.

2026-08-13 20:02; UTC

Galectin Therapeutics Inc shares are higher during Thursday's session, reflecting strong trading activity and unusually high market volume, despite lacking specific company news.

2026-08-12 19:42; UTC

Galectin Therapeutics Inc shares are rising Wednesday amid high trading volume, maintaining an upward trend since Tuesday's close despite pulling back from earlier session highs.

2026-08-11 19:56; UTC

Galectin Therapeutics Inc shares are lower today amid routine fluctuations and no specific news. The stock is near the lower end of its one-month trading range.

2026-08-10 20:02; UTC

Galectin Therapeutics Inc shares are lower today, reflecting a significant decline since Friday amid high trading volume and cautious investor sentiment following a weak jobs report.

2026-08-08 00:01; UTC

Galectin Therapeutics Inc shares are higher in after-market hours, reflecting strong buying activity. The stock has recovered from an early session low.

2026-08-07 23:01; UTC

Galectin Therapeutics Inc shares are higher in after-market hours, recovering from earlier losses amid favorable broader market conditions and a declining unemployment rate.

2026-08-06 22:06; UTC

Galectin Therapeutics Inc shares are lower in after-market trading, continuing a trend below their 20-day moving average amid a significant decline since last month.

2026-08-05 23:02; UTC

Galectin Therapeutics Inc shares are higher in after-market trading, despite no specific news driving the movement. The stock showed significant volatility during the session.

2026-08-04 20:03; UTC

News

Galectin Therapeutics announced a $105.8 million debt-to-equity conversion but shares are lower today after an early peak. Trading volume is unusually high.

2026-08-03 19:46; UTC

Galectin Therapeutics Inc is higher today, continuing an upward trend since Friday's close, despite pulling back from a session high. No specific news was identified.

2026-07-31 21:51; UTC

Galectin Therapeutics Inc is lower in after-market trading, influenced by broader market trends. The asset has faced three consecutive sessions of declines.

2026-07-30 20:10; UTC

Galectin Therapeutics Inc is lower today, breaking a trend of higher daily closes. Increased market volume accompanies the decline amid broader market volatility.

2026-07-29 18:58; UTC

Galectin Therapeutics Inc shares are higher today, continuing an upward trend since Tuesday's close. The stock remains below its 20-day moving average.

2026-07-28 17:46; UTC

Galectin Therapeutics Inc shares are lower today, continuing a decline since Monday's close, amid broader market caution following significant drops in Asian indices.

2026-07-27 16:32; UTC

Galectin Therapeutics Inc shares are lower today, reflecting a notable decline since Friday. The stock has seen unusually high trading volume amid broader market sentiment.

2026-07-24 20:02; UTC

Galectin Therapeutics Inc is lower today, marking its ninth consecutive session of declines. The stock remains below its 20-day moving average.

2026-07-22 19:01; UTC

Galectin Therapeutics Inc. shares are trading lower, following a peak earlier in the session. High trading volume indicates increased investor activity.

2026-07-21 17:16; UTC

Galectin Therapeutics Inc. shares are lower today, continuing a five-session decline and trading significantly below the 20-day moving average. No specific news was identified.

2026-07-20 20:06; UTC

Galectin Therapeutics Inc shares are lower today, continuing a trend of five consecutive daily declines amid broader market volatility linked to geopolitical tensions.

Akcijų palyginimas

Kainos pokytis

Galectin Therapeutics Inc Prognozė

Kainos tikslas

By TipRanks

198.91% į viršų

12 mėnesių prognozė

Vidutinis 11 USD  198.91%

Aukščiausias 11 USD

Žemiausias 11 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Galectin Therapeutics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

1

Pirkti

0

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

150 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Galectin Therapeutics Inc

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, that is in Phase 2b/3 clinical trial, to prevent esophageal varices in patient with non-alcoholic steatohepatitis (NASH) cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and head and neck squamous cell carcinoma. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and develop small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
help-icon Live chat